Who Paid My Doc
Yahia Tagouri
Anatomic Pathology Leonardtown, MD Medical Doctor
NPI 1942383336 CMS profile 447188
2500 Point Lookout Rd, Leonardtown, MD 20650
General payments
$103
Research payments
$0
Ownership & investment interest
$0
Through program year 2023, Yahia Tagouri of Leonardtown, MD is reported in the CMS Open Payments database as having received $103 across 5 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 40th percentile of Anatomic Pathology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
2 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2023 | General | $63 | 3 | |
| 2021 | General | $40 | 2 |
Beside peers
- Yahia Tagouri
- Anatomic Pathology median
- Middle half of Anatomic Pathology
- National median
In program year 2025, general payments to Yahia Tagouri were reported at $0. Among 419 Anatomic Pathology profiles paid that year, the median was $110 and the middle half received between $28 and $974.
Show as a table
| Year | Yahia Tagouri | Anatomic Pathology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $112 | $31–$404 | $163 |
| 2020 | $0 | $185 | $25–$4,265 | $114 |
| 2021 | $40 | $121 | $24–$2,629 | $132 |
| 2022 | $0 | $121 | $31–$1,816 | $149 |
| 2023 | $63 | $96 | $28–$1,008 | $160 |
| 2024 | $0 | $103 | $28–$1,069 | $164 |
| 2025 | $0 | $110 | $28–$974 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 30 billing codesPaid by Medicare
$90,680
Medicare patients
900
Services billed
3,256
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 53% | |
| Diabetes | 49% | |
| Chronic kidney disease | 36% | |
| Ischemic heart disease | 32% | |
| Cancer | 31% | |
| Heart failure | 22% | |
| Atrial fibrillation | 21% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
5 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Anatomic Pathology in Maryland
Debora Gagneten
Anatomic Pathology · Silver Spring, MD
Peter Illei
Anatomic Pathology · Baltimore, MD
Renu Virmani
Anatomic Pathology · Gaithersburg, MD
Tamara Lotan
Anatomic Pathology · Baltimore, MD
Ashley Cimino
Anatomic Pathology · Baltimore, MD
Alexander Baras
Anatomic Pathology · Baltimore, MD
Related records
Anatomic Pathology in Maryland
Practitioners in the same specialty and state, ranked by reported value.
All Anatomic Pathology
Everyone recorded under this specialty, nationwide.
Doctors in Maryland
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.